Sionna Therapeutics Inc (SION)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 37,788 | 0 | 0 | 0 | 38,521 |
| Marketable Securities | 109,750 | 0 | 0 | 0 | 0 |
| Other current assets | 0 | 0 | 0 | 0 | 686 |
| TOTAL | $150,993 | $0 | $0 | $0 | $39,207 |
| Non-Current Assets | |||||
| PPE Net | 2,466 | N/A | N/A | N/A | 4,021 |
| Investments And Advances | 20,505 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 11,788 | 0 | 0 | 0 | 1,006 |
| TOTAL | $34,759 | $N/A | $N/A | $N/A | $5,027 |
| Total Assets | $185,752 | $0 | $0 | $0 | $51,945 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,186 | 0 | 0 | 0 | 719 |
| Accrued Expenses | 8,162 | 0 | 0 | 0 | 6,590 |
| TOTAL | $10,420 | $0 | $0 | $0 | $8,037 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 339,045 | 0 | 0 | 0 | 149,040 |
| TOTAL | $339,045 | $N/A | $N/A | $N/A | $149,040 |
| Total Liabilities | $349,465 | $0 | $0 | $0 | $166,826 |
| Shareholders' Equity | |||||
| Common Shares | 5 | 0 | 0 | 0 | 2 |
| Retained earnings | -181,086 | 0 | 0 | 0 | -119,398 |
| Other shareholders' equity | 368 | 0 | 0 | 0 | 0 |
| TOTAL | $-163,713 | $0 | $0 | $0 | $-114,881 |
| Total Liabilities And Equity | $185,752 | $0 | $0 | $0 | $51,945 |